Via The Guardian:
Italy, Spain and Belgium have joined other European countries in restricting or recommending the use of the Oxford/AstraZeneca vaccine in older age groups as the EU struggles to agree common guidelines to counter expected public hesitancy.
The European Medicines Agency (EMA) on Wednesday found a possible link between the vaccine and very rare cases of blood clots, although it said its benefits far outweighed the risks and did not announce any restrictions.
The HSE is, for now, continuing with its planned rollout of AstraZeneca vaccines to people with underlying health conditions that put them at very high risk from Covid-19.
Any change in guidance would create further obstacles in the State’s protracted vaccine programme given that the AstraZeneca shot accounts for just over 20 per cent of the planned vaccine supplies to the State during the months of April, May and June.